These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

110 related items for PubMed ID: 690847

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Pharmacokinetics of dextromethorphan and dextrorphan: a single dose comparison of three preparations in human volunteers.
    Silvasti M, Karttunen P, Tukiainen H, Kokkonen P, Hänninen U, Nykänen S.
    Int J Clin Pharmacol Ther Toxicol; 1987 Sep; 25(9):493-7. PubMed ID: 3679620
    [Abstract] [Full Text] [Related]

  • 9. Pharmacogenetics of dextromethorphan O-demethylation in man.
    Küpfer A, Schmid B, Pfaff G.
    Xenobiotica; 1986 May; 16(5):421-33. PubMed ID: 3739367
    [Abstract] [Full Text] [Related]

  • 10. Dextromethorphan and dextrorphan as calcium channel antagonists.
    Carpenter CL, Marks SS, Watson DL, Greenberg DA.
    Brain Res; 1988 Jan 26; 439(1-2):372-5. PubMed ID: 2451974
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Dextromethorphan: polymorphic serum pattern of the O-demethylated and didemethylated metabolites in man.
    Mortimer O, Lindström B, Laurell H, Bergman U, Rane A.
    Br J Clin Pharmacol; 1989 Feb 26; 27(2):223-7. PubMed ID: 2713216
    [Abstract] [Full Text] [Related]

  • 13. Comparative antitussive effects of dextrorphan, dextromethorphan and phencyclidine.
    Lal J, Krutak-Krol H, Domino EF.
    Arzneimittelforschung; 1986 Jul 26; 36(7):1075-8. PubMed ID: 3768075
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Comparison of the effects of dextromethorphan, dextrorphan, and levorphanol on the hypothalamo-pituitary-adrenal axis.
    Pechnick RN, Poland RE.
    J Pharmacol Exp Ther; 2004 May 26; 309(2):515-22. PubMed ID: 14742749
    [Abstract] [Full Text] [Related]

  • 16. Dextrorphan and dextromethorphan attenuate hypoxic injury in neuronal culture.
    Goldberg MP, Pham PC, Choi DW.
    Neurosci Lett; 1987 Sep 11; 80(1):11-5. PubMed ID: 3658226
    [Abstract] [Full Text] [Related]

  • 17. Determination of dextromethorphan metabolizer phenotype in healthy volunteers.
    Hildebrand M, Seifert W, Reichenberger A.
    Eur J Clin Pharmacol; 1989 Sep 11; 36(3):315-8. PubMed ID: 2744072
    [Abstract] [Full Text] [Related]

  • 18. Polymorphism of dextromethorphan oxidation in a French population.
    Larrey D, Amouyal G, Tinel M, Letteron P, Berson A, Labbe G, Pessayre D.
    Br J Clin Pharmacol; 1987 Nov 11; 24(5):676-9. PubMed ID: 3435696
    [Abstract] [Full Text] [Related]

  • 19. Effect of liver disease on dextromethorphan oxidation capacity and phenotype: a study in 107 patients.
    Larrey D, Babany G, Tinel M, Freneaux E, Amouyal G, Habersetzer F, Letteron P, Pessayre D.
    Br J Clin Pharmacol; 1989 Sep 11; 28(3):297-304. PubMed ID: 2789923
    [Abstract] [Full Text] [Related]

  • 20. In-vivo and in-vitro dextromethorphan metabolism in SD and DA rat. An animal model of the debrisoquine-type polymorphic oxidation in man.
    Zysset T, Zeugin T, Küpfer A.
    Biochem Pharmacol; 1988 Aug 15; 37(16):3155-60. PubMed ID: 3401246
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 6.